There'll be no letting up on the development of therapeutics by our great pharmaceutical companies that are driving toward a vaccine as soon as it is possible to make available to the public. And there'll be no letting up on continuing to scale testing--already, more than anyone in the world. But by next fall, we'll have a broad range of testing, a variety of different means.